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Abstract
Background
Meniscal tears are common knee injuries. Meniscal allograft transplantation (MAT) has
been advocated to alleviate symptoms and delay osteoarthritis (OA) after meniscectomy.
We investigated (1) the long-term outcome of MAT as a treatment of symptomatic menis-
cectomy, (2) most important factors affecting survivorship and (3) OA progression.
Methods
From 1989 till 2013, 329 MAT were performed in 313 patients. Clinical and radiographic
results and MAT survival were evaluated retrospectively. Failure was defined as conversion
to knee arthroplasty (KA) or total removal of the MAT.
Results
Mean age at surgery was 33 years (15–57); 60% were males. No-to-mild cartilage damage
was found in 156 cases, moderate-to-severe damage in 130. Simultaneous procedures in
118 patients included cartilage procedures, osteotomy or ACL-reconstruction. At a mean
follow-up of 6.8 years (0.2–24.3years), 5 patients were deceased and 48 lost (14.6%), 186
MAT were in situ (56.5%) whilst 90 (27.4%) had been removed, including 63 converted to a
KA (19.2%). Cumulative allograft survivorship was 15.1% (95% CI:13.9–16.3) at 24.0
years. In patients <35 years at surgery, survival was significantly better (24.1%) compared
to ≥35 years (8.0%) (p = 0.017). In knees with no-to-mild cartilage damage more allografts
survived (43.0%) compared to moderate-to-severe damage (6.6%) (p = 0.003). Simulta-
neous osteotomy significantly deteriorated survival (0% at 24.0 years) (p = 0.010). 61% of
patients underwent at least one additional surgery (1–11) for clinical symptoms after MAT.
Consecutive radiographs showed significant OA progression at a mean of 3.8 years
(p<0.0001). Incremental Kellgren-Lawrence grade was +1,1 grade per 1000 days (2,7yrs).
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Conclusions
MAT did not delay or prevent tibiofemoral OA progression. 19.2% were converted to a knee
prosthesis at a mean of 10.3 years. Patients younger than 35 with no-to-mild cartilage dam-
age may benefit from MAT for relief of symptoms (survivorship 51.9% at 20.2 years), but
patients and healthcare payers and providers should be aware of the high number of surgi-
cal re-interventions.
Introduction
Meniscal tears are common injuries. The overall incidence is unknown but the surgical inci-
dence is reported to be 60 to 70 per 100.000 per year [1–3]. Most meniscal tears are caused by
the combination of tissue degeneration and high mechanical loads. Meniscal function may also
be lost because of traumatic events, with or without ligament injury, or congenital malforma-
tion. Meniscectomy through arthrotomy of the knee used to be a common orthopaedic treat-
ment for symptomatic meniscal tears [4]. The advent of arthroscopy significantly reduced the
morbidity of the operative procedure [5,6]. However, the appraised virtues of this new technol-
ogy including its technical elegance, decreased postoperative pain, improved aesthetics and
faster recovery, lowered the threshold to enter the knee joint and perform diagnostic and thera-
peutic interventions, such as ‘partial’meniscectomy. Consequently, the number of procedures
increased exponentially [7] and nowadays patients often undergo repetitive knee arthroscopies
with progressive loss of meniscal volume. In the US, the 2006 National Survey of Ambulatory
Surgery reported approximately one million knee arthroscopies yearly including nearly
500,000 procedures for meniscal tears mostly partial meniscectomies [8].
After meniscectomy, the tibiofemoral contact area is decreased leading to higher contact
stresses between the curved femoral condyle and the flat tibial plateau often associated with
symptoms including pain and instability and a faster progression of tibiofemoral osteoarthritis
(OA) [9]. The first report on the relation between meniscectomy and cartilage degeneration
with bone remodeling dates back to 1948 [10]. In later years, the meniscus was recognized as
an essential structure for biomechanical and biological homeostasis of the knee [11,12]. In a
loaded, ex-vivo setting, the meniscus reduces the stress on the cartilage by load sharing of up to
50% on the medial and 70% on the lateral side [13]. The medial meniscus is an important con-
tributor to knee stability [14] whilst both menisci play a role in shock absorption [15] and joint
lubrication [16]. Recent research revealed an essential biological role of the meniscus in the
development and progression of OA. In vitro pro-inflammatory stimulation of injured menis-
cal tissue causes production of cytokines, chemokines, matrix degrading enzymes and other
catabolic factors by meniscal cells [17–19]. This effect may be enhanced by obesity and/or age-
related dysregulation of anabolic gene expression and changes in cytokine release [17,20,21]. In
vivo, Petty et al demonstrated radiographic signs of OA at 8 to 16 years post-meniscectomy
[22] whilst Cohen et al showed cartilage loss on MRI, 7 years after meniscectomy [23].
Meniscal substitution by meniscal allograft transplantation (MAT) has been advocated to
alleviate clinical symptoms and delay the development and progression of OA especially in
young people [24–26]. MAT follow-up studies have shown encouraging short-term results
regarding healing of the allograft to the joint capsule [24] and symptomatic relief [25] and sug-
gested protection of the articular cartilage [26]. However, none of them could demonstrate that
MAT re-established the load distribution function of the native meniscus and was able to defer
degenerative OA [27,28].
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At Ghent University Hospital, MAT has been performed since 1989 as a surgical option
post-meniscectomy. We conducted a retrospective study evaluating the long-term clinical
results, allograft survivorship and radiographic OA progression. Additional knee interventions
and determinants for success/failure were assessed. Long-term effect of meniscus substitution
on the development and progression of degenerative OA was investigated. Hence the research
questions were: (1) What is the long-term outcome of MAT as a treatment of symptomatic
meniscectomy, (2) which are the most important factors affecting survivorship and (3) does
meniscal substitution delay the development and progression of OA and the need for pros-
thetic reconstructive surgery?
Patients and Methods
Between 1989 and 2013, 329 MAT were performed at Ghent University Hospital by four super-
vising orthopaedic surgeons. Indications were young to middle-aged patients (<60 years) with
moderate to severe knee symptoms (pain, swelling, instability) shortly after total meniscectomy
or after a failed meniscus replacement with an artificial polyurethane meniscus (8 cases) or a
collagen meniscal implant (3 cases). MAT was usually performed during or shortly after com-
plete debridement of the meniscus (total meniscectomy) in patients with recurrent symptoms
after one or several partial meniscectomies. Intact donor meniscal allografts were provided by
the University Hospital Tissue Bank and were matched for size, right/left knee and lateral/
medial meniscus. Donor menisci were used as fresh and viable within two weeks of procure-
ment and storage at 37°C or had been freshly frozen at -80°C. None of the allografts were irra-
diated. MAT were initially performed through a mini-open surgical approach [29] but since
2007 also arthroscopically [30].
We conducted a retrospective review of all MAT. Patients consulting at the department of
orthopaedics and traumatology are asked to sign a generic informed consent giving permission
to use their medical data for retrospective research purposes (approved by Ghent University
Hospital Ethics Committee–B670201317873).
All available demographic, surgical, clinical and radiographic data were collected retrospec-
tively from the University Hospital Electronic Patient Dossiers (EPD). Electronic patient data
recording was started in 1997. Older data from paper records were scanned and stored in the
EPD and could easily be consulted. Demographic data included gender, age at surgery, weight,
length, BMI and smoking history. Data related to MAT included allograft preservation method,
surgical approach, lateral/medial MAT, intraoperative cartilage assessment using the Modified
Outerbridge scale [31] and recording of simultaneous surgeries such as cartilage procedures
(microfractures or osteochondral autograft transfer system (OATS)), high tibial osteotomy
(HTO) or anterior cruciate ligament (ACL) reconstruction. Clinical data included postopera-
tive complications, knee symptoms and subsequent treatments. Additional operations at the
index knee performed at the University Hospital were registered. Only the surgical interven-
tions related to knee morbidity were analyzed. Second-look arthroscopies for suture removal
or allograft biopsies for DNA testing [32] were not taken into account, because we wanted to
focus on re-interventions for clinical symptoms related to the MAT. All available pre-trans-
plantation and consecutive postoperative radiographs were rated according to the Kellgren-
Lawrence radiographic OA scale [33] by two investigators (PB, AE) independently and their
evaluations compared for consistency with the radiologist’s report at the time. Patients who
had not been seen at the clinic recently were contacted by phone, and were asked whether they
agreed to answer a few questions on their MAT. This additional oral consent was noted in the
study spreadsheet. Questions included whether the allograft was still in situ, removed and/or
replaced, and if they had undergone additional knee surgeries at other hospitals. Patients with
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MAT in situ were asked to rate their current pain on a VAS scale from 0 to 10 (0 = no pain;
10 = extreme pain) and to describe any other knee symptoms. Besides, patient satisfaction was
recorded on a VAS scale from 0 to 10 (0 = not satisfied at all; 10 = very satisfied). Patients were
considered ‘lost to follow-up’ if they were not traceable even after very intensive search. Failure
of MAT was defined as total removal of the allograft either by total allograft meniscectomy or
during conversion to a total knee arthroplasty (TKA) or a unicompartmental knee arthroplasty
(UKA) [34]. Partial allograft meniscectomy, tears (sutured or not), degeneration of the donor
meniscus visible on MRI or arthroscopically, meniscal extrusion, and symptomatic knees need-
ing additional treatment were not considered a failure as long as the allograft was not totally
removed.
Statistical analyses were performed using the IBM-SPSS Statistics 22 software (SPSS, an
IBM Company, Chicago, IL, USA) and SAS/STAT Statistical Analysis Software (SAS Institute
Inc., Cary, NC, USA). Statistical tests were verified by a professional statistician (GB). Level of
statistical significance used was 0.05.
The research questions were examined as follows: (1) Life tables and Kaplan-Meier survivor-
ship analysis was performed for the total cohort. For the allografts in situ, outcome scores includ-
ing pain and satisfaction rating by the patients, meniscal re-interventions and other subsequent
knee surgeries were analysed with descriptive statistics. Comparison between different outcome
groups, age groups, cartilage damage and radiographic OA grading groups regarding allograft
time in situ was performed using parametric and non-parametric statistics as appropriate. (2) In
order to establish determinant patient and procedure factors sub-analysis was performed by gen-
der, age at surgery, knee compartment cartilage damage, patient BMI and smoking history, allo-
graft preservation method, open versus arthroscopic surgery, lateral versus medial meniscal
transplantation and concomitant operative procedures. Comparison of survival curves of sub-
groups was performed using log rank (Mantel-Cox) test. Cox proportional-hazards regression
was used to establish most important determining factors for survival. (3) The evolution of OA
progression was evaluated by comparing Kellgren-Lawrence OA grade on consecutive X-rays in
knees with MAT in situ. The difference of radiographic OA grading between consecutive X-rays
was assessed with non-parametric statistics and plotted using a linear regression model (Influ-
ence Statistics) [35]. Difference in grading was also plotted against time and estimated time to
increase at least one Kellgren-Lawrence grade was computed.
Results
329 MAT were implanted in 313 patients from 1989 till 2013. In 6 cases the MAT was replaced
by a new allograft after failure, 5 patients received a MAT in both knees and 5 patients a lateral
and medial MAT at the same knee (Table 1). Mean age at surgery was 33.3 years (15–57 years).
Sixty percent of patients were male. Cartilage damage was assessed during the operation as no
to mild cartilage damage (Outerbridge grade< III) in 156 cases (47.4%) and moderate to severe
damage (grade ≥III) in 130 cases (39.5%); not noted intraoperatively in 43 cases (13.1%). There
was a significant correlation between age and cartilage damage (r = 0.280; p<0.0001). Simulta-
neous concomitant surgeries in 118 cases (35.8%) included cartilage procedures in 52 knees
(15.8%) (50 microfractures; 2 OATS), HTO in 39 cases (11.9%) and ACL reconstruction in 27
knees (8.2%). Postoperative complications occurred in 18 cases (5.5%): 6 septic arthritis, 1
severe synovitis, possibly associated with allograft rejection, 1 deep venous thrombosis, 2 cases
of algoneurodystrophy, 3 arthrofibrosis needing a mobilisation under general anaesthesia and
4 complications related to HTO (3 non-unions and 1 osteomyelitis).
(1) At the time of the retrospective review (locked-down on April 1st 2015), the mean fol-
low-up was 6.8 years (median 5.2 years–range: 2 months to 24.3 years). The outcome of MAT
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at last follow-up is summarized in Fig 1. Five patients died of unrelated causes and 48 (14.6%)
were lost to follow-up. Ninety meniscal allografts (27.4%) had been removed or replaced after a
mean of 8,5 years in situ (median 6,6 years–range 2 months to 24,0 years). Reasons for failure
included pain, synovitis, knee dysfunction, meniscus tear or re-tear. There were 63 conversions
to a knee prosthesis (19.2%) for OA progression: 48 TKA and 15 UKA. At the closure of the
investigation 3 of these TKA had already been revised, including one for infection and 3 UKA
had been converted to a TKA. In 8 additional patients with the allograft in situ a knee prosthe-
sis was planned in the course of 2015 (7 TKA and 1 UKA) which will increase the total number
of conversions to knee arthroplasty to 71 (21.6%). In 27 cases (8.2%) a total meniscectomy was
performed for clinical symptoms with or without extrusion of the graft on MRI, followed by a
re-transplantation with a new MAT in 6 cases.
Time till conversion to a TKA was significantly longer (mean 11.5 years; range 0.5–24.0
years; SD 6.55) compared to a UKA (mean 6.5 years; range 0.7–13.8 years; SD 4.47) (p = 0.002)
Table 1. Patient Demographics: 329 Meniscal Allograft Transplantations in 313 patients.
Gender Male: 187 (60%) Female: 126 (40%)
Age at surgery Mean: 33,3 years (15–57 years)
BMI Mean: 24.9 (16.9–35.7) 9.1% obese (BMI ≥30.0)
Knee Right: 180 (55%) Left: 149 (45%)
Meniscus Lateral: 210 (64%) Medial: 119 (36%)
Allograft preservation Viable: 137 (41.6%) Freshly frozen: 168 (51.1%)
Surgical approach Open: 258 (78%) Arthroscopic: 71 (22%)
Cartilage: modiﬁed Outerbridge grading Grade < III: 156 (47.4%) Grade ≥III: 130 (39.5%)
Concomitant surgeries Simultaneous: 118 (35.8%) Cartilage (microfractures or OATS): 52 (15.8%); High Tibial Osteotomy: 39
(11.9%); fACL reconstruction: 27 (8.2%)
doi:10.1371/journal.pone.0156183.t001
Fig 1. Outcomes of meniscal allograft transplantations (MAT).
doi:10.1371/journal.pone.0156183.g001
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or a total allograft meniscectomy (mean 3.7 years; range 0.2–13.8 years; SD 3.86) (p<0.001).
Mean age at conversion to a TKA was 48.7 years (21–68 years; SD 9.17), and at conversion to a
UKA 43.7 years (34–56 years; SD 6.39).
102 patients with an intact MAT in situ (33%) (no tear, resorption or partial meniscectomy),
reported a median VAS for pain of 5 (mean 4.3; SD 2.7) and a median VAS for satisfaction of 8
(mean 6.7; SD 3.7) at 6.6 years mean follow-up (1.0–24.0 years). Sixteen mentioned recurrent
locking, popping, instability, swelling and/or stiffness of the knee.
Cumulative MAT survivorship with endpoint removal of the allograft (total meniscectomy
or conversion to a knee arthroplasty) was 15.1% (95%CI: 13.9–16.3%) at 24.0 years (Fig 2).
Mean survival time was 15.2 years.
(2) There was no significant difference in MAT survivorship between genders (p = 0.552),
right or left knee (p = 0.080), lateral or medial MAT (p = 0.837), BMI categories (p = 0.211),
smokers or non-smokers (p = 0.235) and MAT preservation method (viable or fresh-frozen)
(p = 0.118). Open versus arthroscopic surgical approach had no significant influence on sur-
vival so far (p = 0.851) but the longest follow-up time was only 7.4 years for the arthroscopic
approach compared to 24.3 years for the open approach (p<0.001). In patients younger than
35 at surgery, survival was significantly better (24.1% (95%CI: 21.4–26.7%)) at 24 years; mean
Fig 2. Kaplan-Meier cumulative survivorship of all MAT: endpoint removal of the allograft by total meniscectomy
or during conversion to a knee arthroplasty (TKA or UKA).
doi:10.1371/journal.pone.0156183.g002
Meniscal Substitution Does Not Prevent Knee Osteoarthritis
PLOS ONE | DOI:10.1371/journal.pone.0156183 May 26, 2016 6 / 14
survival time 16.7 years) compared to older patients (8.1% (95%CI: 7.2–9.0%)) at 24 years;
mean survival time 13.8 years) (p = 0.017). The odds ratio of MAT failure was 2.3 in the ≥35
years group compared to the<35 group. Yet, even in the group<35 years at surgery, 12% had
been converted to a KA (15TKA/6UKA) at a mean of 13 years post-MAT for TKA and 9 years
post-MAT for UKA. In the group<35 years at surgery there was no difference in survivorship
between genders (at 24 years Males: 26.6% (95%CI: 23.3–29.9%); Females: 27.4% (95%CI:
21.2–33.6%)—p = 0.262) (Fig 3) or lateral versus medial meniscus (at 24 years Lateral: 37.4%
(95%CI: 31.5–43.3%) Medial: 18.9% (95%CI: 15.8–22.0%)—p = 0.738) (Fig 4).
In knees with no-to-mild cartilage damage (Outerbridge grade<III) more allografts sur-
vived (43.0% (95%CI: 38.4–47.6%) at 24 years; mean survival time 17.6 years) compared to
moderate-to-severe damage (Outerbridge grade ≥III) (6.6% (95%CI: 5.8–7.4%) at 24 years;
mean survival time 13.4 years) (p = 0.003). The odds ratio of MAT failure was 3.7 in the grade
≥III group compared to<III. In the group with no to mild cartilage damage at surgery there
was no difference in survivorship between genders (Males: 41.3% (95%CI: 36.0–46.6%)
Females: 59.4% (95%CI: 48.5–70.3%) at 24 years—p = 0.901) (Fig 5) or lateral versus medial
Fig 3. Kaplan-Meier cumulative survivorship of MAT in the <35 years at surgery group—gender: no
statistically significant difference betweenmales (blue line) and females (green line) (p = 0.262).
doi:10.1371/journal.pone.0156183.g003
Fig 4. Kaplan-Meier cumulative survivorship of MAT in the <35 years at surgery group–lateral/medial:
no statistically significant difference between lateral (blue line) andmedial (green line) MAT
(p = 0.738).
doi:10.1371/journal.pone.0156183.g004
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meniscus (Lateral: 69.8% (95%CI: 60.7–78.9%) Medial: 31.5% (95%CI: 26.7–36.3%) at 24 years
—p = 0.591) (Fig 6).
Simultaneous HTO significantly deteriorated survival (0% at 24.0 years, mean survival time
11.2 years, range: 2 months to 24 years) (p = 0.010). Concomitant microfractures or ACL
reconstruction did not have a significant influence on MAT survivorship (p = 0.983 and
p = 0.272 respectively). In the group with concomitant microfractures 11 out of 50 were con-
verted to a TKA (22%).
61% of patients underwent one or more surgical re-interventions (30% two or more, 14%
three or more subsequent operations; mean 2.0; range 1 to 11) at the University Hospital for
clinical symptoms at the index knee after MAT. Some patients underwent multiple further
knee surgeries at other hospitals. Cox regression analysis indicated that age ≥35 years at surgery
and cartilage grade ≥III were the most important determinants of failure of MAT. Best case
scenario were patients<35 years at surgery with no to little cartilage damage (Outerbridge
grade<III) (n = 85) with a cumulative survivorship of 51.9% (95%CI 45.0–58.8%) at 20.2 years
Fig 5. Kaplan-Meier cumulative survivorship of MAT in the cartilage Outerbridge grade < III group—
gender: no statistically significant difference betweenmales (blue line) and females (green line)
(p = 0.901).
doi:10.1371/journal.pone.0156183.g005
Fig 6. Kaplan-Meier cumulative survivorship of MAT in the cartilage Outerbridge grade < III group–
lateral/medial: no statistically significant difference between lateral (blue line) andmedial (green line)
MAT (p = 0.591).
doi:10.1371/journal.pone.0156183.g006
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(mean survival 19 years) whilst worst case scenario were patients ≥35 at surgery with moderate
to severe cartilage damage (grade III-V) (n = 77) with a survival of 6.3% (95%CI 5.3–7.3%) at
22.3 years (mean survival time 12.7 years) (Fig 7).
(3) Consecutive standard radiographs of 107 knees with MAT in situ showed significant
tibiofemoral OA progression on the Kellgren-Lawrence scale with time (p<0.0001) (mean
1385 days (3.8 years); range 1 month to 21.6 years; SD 4.2 years—no evolution in 40.2%; grade
+1 in 34.6%; grade +2 in 20.6%; grade +3 in 4.7%) (Fig 8). The mean incremental gradient was
+1.1 Kellgren-Lawrence grade per 1000 days (2,7yrs) (Fig 9). In cases with concomitant micro-
fractures, there was a trend towards a slower evolution of OA with an increased Kellgren-Law-
rence grade of +0.7 per 1000 days. The group of patients who evolved more than 2 grades on
the Kellgren-Lawrence scale had a higher BMI distribution (p = 0.02). There was no significant
difference in progression of OA on the Kellgren-Lawrence scale with age (p = 0.109) (Fig 10),
gender (p = 0.951) or lateral versus medial MAT (p = 0.539).
Discussion
Meniscus substitution with a MAT has been advocated to alleviate symptoms of pain and insta-
bility after (partial) meniscectomy and to delay OA progression [24–26]. Pengas et al prospec-
tively followed a cohort of 53 adolescents who had undergone meniscectomy [36]. Additional
surgery was not performed till OA progression necessitated arthroplasty. At a mean follow-up
of 40 years, 13.2% had received a TKA. The relative risk of OA assessed radiographically with
the Kellgren-Lawrence scale was 4.5 compared to the non-operated knee at 40 years [36]. Par-
tial meniscectomy was also shown to increase the risk for development of OA although less
than total meniscectomy [37]. The current retrospective study of MAT was undertaken to eval-
uate the outcome of meniscal replacement after meniscectomy and to assess whether progres-
sion of knee OA was effectively delayed or prevented. The main strength of our study is that it
comprises the largest patient cohort treated with MAT with the longest follow-up.
Fig 7. Kaplan-Meier survivorship curve (blue line) of the best case scenario (age <35 years at surgery
and cartilage Outerbridge grade < III: n = 85) versus Kaplan-Meier survivorship curve (red line) of the
worst case scenario (Age ≥35 years at surgery and Cartilage Outerbridge grade ≥ III: n = 77).
doi:10.1371/journal.pone.0156183.g007
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The study has several limitations. Due to its retrospective nature and the long-term follow-
up up to 24 years, 14.6% of patients were lost and prospective clinical scores were not available.
Fig 8. Fit-plot regression curve for evolution of Kellgren-Lawrence grade on consecutive
radiographs.
doi:10.1371/journal.pone.0156183.g008
Fig 9. Fit-plot regression curve for difference in Kellgren-Lawrence grade on consecutive
radiographs over time.
doi:10.1371/journal.pone.0156183.g009
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However, despite the complexity of the retrospective evaluation, it is important to establish a
comprehensive record of MAT as a treatment involving human donor transplant material. A
second limitation consists in the absence of a control group receiving conservative treatment
[38–40]. Several authors have demonstrated comparable relief of clinical symptoms with physi-
cal therapy versus partial meniscectomy [38–40]. Concurrently, our results demonstrate that
meniscal substitution constitutes only a temporary solution for relief of symptoms after menis-
cectomy. In our study, MAT was usually performed during or shortly after complete debride-
ment of the meniscus (total meniscectomy) in patients with recurrent symptoms after one or
several partial meniscectomies. As the initial partial meniscectomies were often performed at
other hospitals, we have no accurate data on the time between the first partial meniscectomy
and the MAT. A third limitation is that OA progression was evaluated only by use of the Kellg-
ren-Lawrence scale on standard radiographs. A standardized, consecutive MRI assessment of
the articular cartilage was not available for most patients. A prospective MRI study would pro-
vide an earlier and more accurate short-term evaluation of OA evolution [41]. However, Zaf-
fagnini et al showed no significant difference in 5 years progression of cartilage damage on
MRI after meniscal substitution with a Collagen Meniscal Implant (CMI) compared to menis-
cectomy without meniscal replacement [42]. Moreover, in our study, we were able to demon-
strate OA advancement on consecutive standard radiographs, indicating definite cartilage
deterioration. Besides, progression of OA led to 19.1% conversions to a knee arthroplasty at a
mean of 11.5 years for TKA and 6.5 years for UKA.
In answer to our research questions, we found that (1) Overall cumulative survivorship of
MAT was 15.1% at 24 years with a mean survival of 15.2 years. Over 50% of patients with the
MAT in situ reported knee pain and/or other symptoms but most of them were satisfied with
the outcome. However, the high number of subsequent knee interventions for symptoms, tear
or failure of the MAT is concerning as it was associated with morbidity, (temporary) disability
and socio-economic costs. In this regard, it is worth considering that Katz et al showed no dif-
ference in relief of symptoms between partial meniscectomy and physical therapy versus physi-
cal therapy alone in patients with meniscal tear and OA [40]. Besides, Sihvonen et al
Fig 10. Distribution of age versus progression of grade of radiographic OA on the Kellgren-Lawrence
scale (+ 0, 1, or 2 grades): no statistically significant difference (p = 0.109).
doi:10.1371/journal.pone.0156183.g010
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demonstrated that partial meniscectomy as a treatment of degenerative meniscal tears was not
superior to sham arthroscopy [43].
(2) Most important determinants of success of the MAT were age younger than 35 years at
surgery and no to mild cartilage damage (Outerbridge grade< III). Concomitant HTO had a
negative effect on survival. We could not prove a significant positive effect of simultaneous car-
tilage procedures on MAT survival although concomitant microfractures were associated with
a trend to slower radiographic OA progression.
(3) Delay or prevention of OA by meniscal substitution after meniscectomy could not be
demonstrated in this study. On the contrary, there was a significant radiographic evolution of
OA. Overall, 63 MAT (19.2%) were converted to a knee prosthesis whilst 8 additional knee
arthroplasties were planned (total 71 or 21.6%). Even in the group<35 years at surgery, 21
MAT (12%) were converted to a knee prosthesis (15TKA/6UKA) at a mean of 13 years post-
MAT for TKA and 9 years for UKA. These results are comparable to the report of 13.2% TKA
at a mean of 40 years after meniscectomy in adolescents who did not receive any additional
surgical treatment [36]. In our study, the mean age of patients at knee arthroplasty was sub-
stantially younger (48.7 years for TKA; 43.7 years for UKA) compared to large series of TKA
and UKA reporting mean ages at surgery of over 60 years [44,45]. In the group less than 35
years at MAT, who were converted to a KA, the mean age at knee arthroplasty was even youn-
ger: 43.2 years (21–57) for TKA and 40.7 years (34–44) for UKA.
Our results regarding OA progression are concordant with a meta-analysis concluding that
the majority of studies could not demonstrate a protective effect of MAT on cartilage and that
therefore, based on the current literature, MAT does not prevent or delay OA [46]. Another lit-
erature review of 24 studies cautioned that MAT may delay the progression of damaged carti-
lage but does not prevent degeneration of previously healthy cartilage [47]. Whether these
findings are related to cartilage degeneration initiated by meniscal injury [19] or by repetitive
surgical trauma [41], or to the inability of the MAT to reproduce the biomechanical and bio-
logical function of the native meniscus, remains to be investigated.
Conclusions
Our study indicates that meniscal allograft transplantation (MAT) performs well in patients
younger than 35 with no-to-mild cartilage damage. These patients may benefit from MAT for
relief of symptoms, but patients and healthcare payers and providers should be aware of the
high number of surgical re-interventions. There is no evidence that MAT prevents or delays
tibiofemoral OA progression.
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